Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2837)
All Articles published online
|
Mar 28, 2005 (publication date) through Apr 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Chen M, Li YG, Zhang DZ, Wang ZY, Zeng WQ, Shi XF, Guo Y, Guo SH, Ren H. Therapeutic effect of autologous dendritic cell vaccine on patients with chronic hepatitis B: A clinical study. World J Gastroenterol 2005; 11(12): 1806-1808 [PMID: 15793869 DOI: 10.3748/wjg.v11.i12.1806] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i12/1806.htm |
| Number | Citing Articles |
| 1 |
Sheeba Khan, Reenam S. Khan, Philip N. Newsome. Cell Therapy for Liver Disease: From Promise to Reality. Seminars in Liver Disease 2020; 40(04): 411 doi: 10.1055/s-0040-1717096
|
| 2 |
Xiaomeng Hu, Tingting Wu, Xianya Qin, Yan Qi, Qi Qiao, Conglian Yang, Zhiping Zhang. Tumor Lysate‐Loaded Lipid Hybrid Nanovaccine Collaborated with an Immune Checkpoint Antagonist for Combination Immunotherapy. Advanced Healthcare Materials 2019; 8(1) doi: 10.1002/adhm.201800837
|
| 3 |
E. M. Martinez, J. J. Cancela, T. S. Cuesta, X. X. Neira. Review. Use of psychrometers in field measurements of plant material: accuracy and handling difficulties. Spanish Journal of Agricultural Research 2011; 9(1): 313 doi: 10.5424/sjar/20110901-295-10
|
| 4 |
Daniel O Villarreal, Kendra T Talbott, Daniel K Choo, Devon J Shedlock, David B Weiner. Synthetic DNA vaccine strategies against persistent viral infections. Expert Review of Vaccines 2013; 12(5): 537 doi: 10.1586/erv.13.33
|
| 5 |
Sheikh MF Akbar, Mamun Al-Mahtab, Sakirul I Khan, Ananta Shrestha, Shahina Tabassum, Yoichi Hiasa. Current trends in hepatitis B vaccination. Future Virology 2016; 11(5): 369 doi: 10.2217/fvl-2016-0025
|
| 6 |
涛 巫. Immunotherapy for Chronic Hepatitis B Virus Infection. Pharmacy Information 2019; 8(03): 105 doi: 10.12677/PI.2019.83013
|
| 7 |
Sheikh Mohammad Fazle Akbar, Mamun Al Mahtab, Osamu Yoshida, Julio Aguilar, Guillen Nieto Gerardo, Yoichi Hiasa. Development of Therapy Based on the Exploration of Biological Events Underlying the Pathogenetic Mechanisms of Chronic Hepatitis B Infection. Biomedicines 2023; 11(7): 1944 doi: 10.3390/biomedicines11071944
|
| 8 |
Olga Yu. Leplina, Tamara V. Tyrinova, Marina A. Tikhonova, Alexander A. Ostanin, Elena R. Chernykh. Interferon alpha induces generation of semi-mature dendritic cells with high pro-inflammatory and cytotoxic potential. Cytokine 2015; 71(1): 1 doi: 10.1016/j.cyto.2014.07.258
|
| 9 |
Y.‐J. Ma, M. He, J.‐A. Han, L. Yang, X.‐Y. Ji. A Clinical Study of HBsAg‐Activated Dendritic Cells and Cytokine‐Induced Killer Cells During the Treatment for Chronic Hepatitis B. Scandinavian Journal of Immunology 2013; 78(4): 387 doi: 10.1111/sji.12097
|
| 10 |
Sheikh Mohammad Fazle Akbar, Mamun Al-Mahtab, Mohammad Helal Uddin, Md. Sakirul Islam Khan. HBsAg, HBcAg, and combined HBsAg/HBcAg-based therapeutic vaccines in treating chronic hepatitis B virus infection. Hepatobiliary & Pancreatic Diseases International 2013; 12(4): 363 doi: 10.1016/S1499-3872(13)60057-0
|
| 11 |
Jin Luo, Jun Li, Rui L. Chen, Lei Nie, Jie Huang, Zheng W. Liu, Lin Luo, Xiao J. Yan. Autologus dendritic cell vaccine for chronic hepatitis B carriers: A pilot, open label, clinical trial in human volunteers. Vaccine 2010; 28(13): 2497 doi: 10.1016/j.vaccine.2010.01.038
|
| 12 |
A. K. Vyas, A. Jindal, S. Hissar, G. Ramakrishna, N. Trehanpati. Immune balance in Hepatitis B Infection: Present and Future Therapies. Scandinavian Journal of Immunology 2017; 86(1): 4 doi: 10.1111/sji.12553
|
| 13 |
Monique T. A. de Beijer, Diahann T. S. L. Jansen, Yingying Dou, Wim J. E. van Esch, Juk Yee Mok, Mariëlle J. P. Maas, Giso Brasser, Robert A. de Man, Andrea M. Woltman, Sonja I. Buschow, J.-H. James Ou. Discovery and Selection of Hepatitis B Virus-Derived T Cell Epitopes for Global Immunotherapy Based on Viral Indispensability, Conservation, and HLA-Binding Strength. Journal of Virology 2020; 94(7) doi: 10.1128/JVI.01663-19
|
| 14 |
Darren J. Wong, Stephen A. Locarnini, Alexander J.V. Thompson. Clinical Virology. 2016; : 713 doi: 10.1128/9781555819439.ch32
|
| 15 |
Vinod K Rustgi, Raymond S Koff. Future therapy for hepatitis B. Future Virology 2007; 2(1): 79 doi: 10.2217/17460794.2.1.79
|
| 16 |
Wei Zhao, Wangying Hu, Xiaolong Wang, Nan Xia, Qixiang Hu, Hua Zhou. A traditional Chinese medicine, Lujiao prescription, as a potential therapy for hypertrophic cardiomyocytes by acting on histone acetylation. Journal of the Chinese Medical Association 2015; 78(8): 486 doi: 10.1016/j.jcma.2015.03.006
|
| 17 |
Laura Ochoa‐Callejero, Pedro Berraondo, Julien Crettaz, Cristina Olagüe, África Vales, Juan Ruiz, Jesús Prieto, Bud C. Tennant, Stephan Menne, Gloria González‐Aseguinolaza. Woodchuck dendritic cells generated from peripheral blood mononuclear cells and transduced with recombinant human adenovirus serotype 5 induce antigen‐specific cellular immune responses. Journal of Medical Virology 2007; 79(5): 522 doi: 10.1002/jmv.20808
|
| 18 |
Sheikh Mohammad Fazle Akbar, Mamun Al Mahtab, Julio Cesar Aguilar, Md. Helal Uddin, Md. Sakirul Islam Khan, Osamu Yoshida, Eduardo Penton, Guillen Nieto Gerardo, Yoichi Hiasa. Exploring evidence-based innovative therapy for the treatment of chronic HBV infection: experimental and clinical. Exploration of Medicine 2021; doi: 10.37349/emed.2021.00058
|
| 19 |
Norihisa Sakamoto, Kazuhide Tsuji, Linda M. Muul, Ann M. Lawler, Emanuel F. Petricoin, Fabio Candotti, Julia A. Metcalf, Jorge A. Tavel, H. Clifford Lane, Walter J. Urba, Bernard A. Fox, Ajit Varki, Joan K. Lunney, Amy S. Rosenberg. Bovine apolipoprotein B-100 is a dominant immunogen in therapeutic cell populations cultured in fetal calf serum in mice and humans. Blood 2007; 110(2): 501 doi: 10.1182/blood-2007-01-066522
|
| 20 |
Sheikh Akbar, Mamun Mahtab, Sakirul Khan, Osamu Yoshida, Yoichi Hiasa. Development of Therapeutic Vaccine for Chronic Hepatitis B: Concept, Cellular and Molecular Events, Design, Limitation, and Future Projection. Vaccines 2022; 10(10): 1644 doi: 10.3390/vaccines10101644
|
| 21 |
Mehdi Ghasemi, Murat Erturk, Kurtulus Buruk, Mehmet Sonmez. Induction of potent protection against acute and latent herpes simplex virus infection in mice vaccinated with dendritic cells. Cytotherapy 2013; 15(3): 352 doi: 10.1016/j.jcyt.2012.11.012
|
| 22 |
Hai‐hua Sun, Dong‐fang Zhou, Jun‐ying Zhou. The role of DCs in the immunopathogenesis of chronic HBV infection and the methods of inducing DCs maturation. Journal of Medical Virology 2016; 88(1): 13 doi: 10.1002/jmv.24306
|
| 23 |
Prakriti Sinha, Parul Sahu. Dynamics of Immune Activation in Viral Diseases. 2020; : 205 doi: 10.1007/978-981-15-1045-8_14
|
| 24 |
Jonny Jonny, Terawan Agus Putranto, Enda Cindylosa Sitepu, Raoulian Irfon. Dendritic cell vaccine as a potential strategy to end the COVID-19 pandemic. Why should it be Ex Vivo?. Expert Review of Vaccines 2022; 21(8): 1111 doi: 10.1080/14760584.2022.2080658
|
| 25 |
Sk Md Fazle Akbar, Norio Horiike, Morikazu Onji. Immune therapy including dendritic cell based therapy in chronic hepatitis B virus infection. World Journal of Gastroenterology 2006; 12(18): 2876-2883 doi: 10.3748/wjg.v12.i18.2876
|
| 26 |
Liangen Chen, Zheng Zhang, Weiwei Chen, Zhidong Zhang, Yonggang Li, Ming Shi, Jiyuan Zhang, Lieping Chen, Shengdian Wang, Fu-Sheng Wang. B7-H1 Up-Regulation on Myeloid Dendritic Cells Significantly Suppresses T Cell Immune Function in Patients with Chronic Hepatitis B. The Journal of Immunology 2007; 178(10): 6634 doi: 10.4049/jimmunol.178.10.6634
|
| 27 |
I. O. Chikileva, I. Zh. Shubina, M. V. Kiselevskiy. Modern antiviral biomedical cell products and their applications for COVID-19 therapy. Russian Journal of Biotherapy 2022; 21(2): 19 doi: 10.17650/1726-9784-2022-21-2-19-32
|
| 28 |
M Shi, S Qian, W-W Chen, H Zhang, B Zhang, Z-R Tang, Z Zhang, F-S Wang. Hepatitis B virus (HBV) antigen-pulsed monocyte-derived dendritic cells from HBV-associated hepatocellular carcinoma patients significantly enhance specific T cell responsesin vitro. Clinical and Experimental Immunology 2007; 147(2): 277 doi: 10.1111/j.1365-2249.2006.03281.x
|
| 29 |
Xuejie Wu, Feng Xu. Dendritic cell‐based immunotherapy: A potential therapeutic option for chronic Hepatitis B virus infection. Clinical and Translational Discovery 2023; 3(1) doi: 10.1002/ctd2.173
|
| 30 |
Adam J. Gehring, June Ann D'Angelo. Dissecting the dendritic cell controversy in chronic hepatitis B virus infection. Cellular & Molecular Immunology 2015; 12(3): 283 doi: 10.1038/cmi.2014.95
|
| 31 |
Anthony Tanoto Tan, Sarene Koh, Vera Goh, Antonio Bertoletti. Understanding the immunopathogenesis of chronic hepatitis B virus: An Asian prospective. Journal of Gastroenterology and Hepatology 2008; 23(6): 833 doi: 10.1111/j.1440-1746.2008.05385.x
|
| 32 |
Laís Teodoro da Silva, Bruna Tereso Santillo, Alexandre de Almeida, Alberto Jose da Silva Duarte, Telma Miyuki Oshiro. Using Dendritic Cell-Based Immunotherapy to Treat HIV: How Can This Strategy be Improved?. Frontiers in Immunology 2018; 9 doi: 10.3389/fimmu.2018.02993
|
| 33 |
|
| 34 |
Min Chen, Dazhi Zhang, Weiqun Zhen, Qingfeng Shi, Yi Liu, Ning Ling, Mingli Peng, Kaifu Tang, Peng Hu, Huaidong Hu, Hong Ren. Characteristics of Circulating T Cell Receptor γδ T Cells from Individuals Chronically Infected with Hepatitis B Virus (HBV): An Association between Vδ2 Subtype and Chronic HBV Infection. The Journal of Infectious Diseases 2008; 198(11): 1643 doi: 10.1086/593065
|
| 35 |
Diahann TSL Jansen, Yingying Dou, Janet W de Wilde, Andrea M Woltman, Sonja I Buschow. Designing the next‐generation therapeutic vaccines to cure chronic hepatitis B: focus on antigen presentation, vaccine properties and effect measures. Clinical & Translational Immunology 2021; 10(1) doi: 10.1002/cti2.1232
|
| 36 |
Sheikh Mohammad Fazle Akbar, Osamu Yoshida, Yoichi Hiasa. Immune therapies against chronic hepatitis B. Journal of Gastroenterology 2022; 57(8): 517 doi: 10.1007/s00535-022-01890-8
|
| 37 |
Sheikh Mohammad Fazle Akbar, Mamun Al-Mahtab, Md. Sakirul Islam Khan. Non-antigen-specific and antigen-specific immune therapies for chronic hepatitis B: evidences from laboratory benches and patient's bedsides. Expert Opinion on Biological Therapy 2013; 13(7): 1063 doi: 10.1517/14712598.2013.789016
|
| 38 |
Ethel Atanley, Sylvia van Drunen Littel-van den Hurk. Future considerations for dendritic cell immunotherapy against chronic viral infections. Expert Review of Clinical Immunology 2014; 10(6): 801 doi: 10.1586/1744666X.2014.907742
|
| 39 |
Jianqiang Li, Mengru Bao, Jun Ge, Sulin Ren, Tong Zhou, Fengchun Qi, Xiuying Pu, Jia Dou. Research progress of therapeutic vaccines for treating chronic hepatitis B. Human Vaccines & Immunotherapeutics 2017; 13(5): 986 doi: 10.1080/21645515.2016.1276125
|
| 40 |
Rajan George, Allan Ma, Bruce Motyka, Yuenian Eric Shi, Qiang Liu, Philip Griebel. A dendritic cell-targeted chimeric hepatitis B virus immunotherapeutic vaccine induces both cellular and humoral immune responsesin vivo. Human Vaccines & Immunotherapeutics 2020; 16(4): 779 doi: 10.1080/21645515.2019.1689081
|
| 41 |
Sheikh Mohammad Fazle Akbar, Mamun Al-Mahtab, Yoichi Hiasa. Designing Immune Therapy for Chronic Hepatitis B. Journal of Clinical and Experimental Hepatology 2014; 4(3): 241 doi: 10.1016/j.jceh.2014.06.008
|
| 42 |
Yin Huang, Zhi Chen, Hongyu Jia, Wei Wu, Shigen Zhong, Cheng Zhou. Induction of Tc1 response and enhanced cytotoxic T lymphocyte activity in mice by dendritic cells transduced with adenovirus expressing HBsAg. Clinical Immunology 2006; 119(3): 280 doi: 10.1016/j.clim.2006.01.015
|
| 43 |
Fu‐Sheng Wang. Clinical immune characterization of hepatitis B virus infection and implications for immune intervention: Progress and challenges. Hepatology Research 2007; 37(s3) doi: 10.1111/j.1872-034X.2007.00222.x
|
| 44 |
Irina Chikileva, Irina Shubina, Anzhelika-Mariia Burtseva, Kirill Kirgizov, Nara Stepanyan, Svetlana Varfolomeeva, Mikhail Kiselevskiy. Antiviral Cell Products against COVID-19: Learning Lessons from Previous Research in Anti-Infective Cell-Based Agents. Biomedicines 2022; 10(4): 868 doi: 10.3390/biomedicines10040868
|
| 45 |
David C. Jackson, Georgia Deliyannis, Emily Eriksson, Irene Dinatale, Michael Rizkalla, Eric J. Gowans. Dendritic Cell Immunotherapy of Hepatitis C Virus Infection: Toxicology of Lipopeptide-Loaded Dendritic Cells. International Journal of Peptide Research and Therapeutics 2005; 11(4): 223 doi: 10.1007/s10989-005-9270-y
|
| 46 |
Mei-Juan Wei, Xing-Nan Pan, Kai-Peng Wei, Xu-Hong Li, Xiao-Long Liu, Xiao-Man Zhang, Ya-Ling Jiang, Chun-Yu Zhang, Jian-Kun Shen. Efficacy of HBV-pulsed DCs in combination with entecavir in patients with chronic hepatitis B infection. International Immunopharmacology 2015; 27(2): 238 doi: 10.1016/j.intimp.2015.06.019
|
| 47 |
Sheikh Mohammad Fazle Akbar, Mamun Al-Mahtab, Munira Jahan, Osamu Yoshida, Yoichi Hiasa. Novel insights into immunotherapy for hepatitis B patients. Expert Review of Gastroenterology & Hepatology 2016; 10(2): 267 doi: 10.1586/17474124.2016.1112266
|
| 48 |
Rong Li, Xiufen Zheng, Igor Popov, Xusheng Zhang, Hongmei Wang, Motohiko Suzuki, Rosalia De Necochea-Campion, Peter W French, Di Chen, Leo Siu, David Koos, Robert D Inman, Wei-Ping Min. Gene silencing of IL-12 in dendritic cells inhibits autoimmune arthritis. Journal of Translational Medicine 2012; 10(1) doi: 10.1186/1479-5876-10-19
|
| 49 |
Nathalie Cools, Annacarmen Petrizzo, Evelien Smits, Franco M Buonaguro, Maria L Tornesello, Zwi Berneman, Luigi Buonaguro. Dendritic cells in the pathogenesis and treatment of human diseases: a Janus Bifrons?. Immunotherapy 2011; 3(10): 1203 doi: 10.2217/imt.11.110
|